This study investigates the use of virtual reality (VR) for managing pain in patients with gastrointestinal (GI) cancer. It focuses on how VR can affect patient-reported outcomes related to pain and overall health.
The study evaluates the effectiveness of different VR therapies, including skills-based and distraction-based approaches, to see how they impact pain levels and opioid use.
- Who can participate: Adults with GI cancer who have significant belly pain and can read and write in English may participate. Those with certain medical conditions or cognitive impairments may not be eligible.
- Study details: Participants will use VR headsets daily for four weeks, experiencing either skills-based or distraction-based VR content. A placebo group will watch 2D videos.
- Study timelines: The study will last 60 days.
How understandable was the trial content above?
Hard to understand
Easy to understand